|1.||Vorozhtsov, G N: 4 articles (12/2008 - 11/2007)|
|2.||Uzdensky, Anatoly: 3 articles (02/2013 - 10/2002)|
|3.||Kuz'min, S G: 3 articles (01/2008 - 11/2007)|
|4.||Kiesslich, Tobias: 2 articles (01/2013 - 03/2002)|
|5.||Krammer, Barbara: 2 articles (01/2013 - 03/2002)|
|6.||Plaetzer, Kristjan: 2 articles (01/2013 - 03/2002)|
|7.||Likhvantseva, V G: 2 articles (01/2008 - 01/2008)|
|8.||Shevchik, S A: 2 articles (01/2008 - 11/2007)|
|9.||Loshchenov, V B: 2 articles (01/2008 - 11/2007)|
|10.||Merzliakova, O Iu: 2 articles (01/2008 - 01/2008)|
01/01/2008 - "The authors analyze and present the results of spectroscopic studies into changes in the accumulation of the photosensitizer Photosens, its elimination kinetics and distribution in the tissues of the eye and eyelids, as well as in the tumors that have developed at these sites. "
09/01/2015 - "The illumination of the tumors during PET imaging provoked a net decrease of (18)FDG uptake in tumors treated with AlPcS4 and a near total absence of (18)FDG uptake in tumors treated with ZnPcS2. "
01/01/1997 - "The in vivo spectrum of AlPcS4 both in the EMT6/Ed tumor model and the Dunning R3327-AT tumor model differs from the spectrum of AlPcS4 in saline. "
04/01/1996 - "IP AlPcS4 (2.5 mg/kg) was injected when tumors were visible. "
04/01/1992 - "A fluorescent dye, chloro-aluminum phthalocyanine tetrasulfonate (ClAlPcS4), was injected intravenously 24 hours before tumor resection. "
|2.||Breast Neoplasms (Breast Cancer)
09/22/2015 - "PDT of breast cancer cells following 4 h of incubation with various formula revealed the following cell destruction rate: ∼10% with free AlPcS4, ∼23% with singly layered Au NR/(AlPcS4)1 complex, and ∼50% with doubly layered Au NR/(AlPcS4)2. Incubation with Au NR/(AlPcS4)2 for an additional 2 h resulted in ∼85% cell killing, more than 8-fold increase compared to AlPcS4 alone. "
09/22/2015 - "A layer-by-layer (LbL) assembly strategy was used to incorporate high concentrations of Al(III) phthalocyanine chloride tetrasulfonic acid (AlPcS4) photosensitizer (PS) onto plasmonic Au nanorings (Au NRs) for increasing the cellular uptake of AlPcS4 and subsequently enhancing the efficacy of photodynamic therapy (PDT) of human breast cancer cells (MDA-MB-231) in the near-infrared (NIR) range. "
03/01/1999 - "Inhibition of various steps in the replication cycle of vesicular stomatitis virus contributes to its photoinactivation by AlPcS4 or Pc4 and red light."
10/01/1992 - "Treatment of a human RBCC with 10-13 microM AlPcS4 and 25-26 mW/cm2 visible light resulted in the rapid and complete inactivation of added vesicular stomatitis virus (VSV). "
03/01/1997 - "Vesicular stomatitis virus (VSV) was used as a model virus to study the primary targets of photoinactivation by aluminum phthalocyanine tetrasulfonate (AIPcS4) or silicon phthalocyanine HOSiPcOSi(CH3)2(CH2)3N(CH3)2 (Pc4) and red light. "
03/01/1999 - "Vesicular stomatitis virus (VSV) was used as a model virus to study the processes involved in photoinactivation by aluminum phthalocyanine tetrasulfonate (AlPcS4) or silicon phthalocyanine HOSiPcOSi(CH3)2(CH2)3N(CH3)2 (Pc4) and red light. "
|4.||Phototoxic Dermatitis (Phototoxicity)
03/01/1994 - "Under all experimental conditions, the phototoxicity of ZnPcS4 was markedly higher than that of AlPcS4. "
05/01/1990 - "Laser-induced photodynamic therapy with aluminum phthalocyanine tetrasulfonate as the photosensitizer: differential phototoxicity in normal and malignant human cells in vitro."
05/01/1990 - "In this study, we have examined laser-induced phototoxicity in normal human skin fibroblasts and HT-1080 fibrosarcoma cells incubated with aluminum phthalocyanine tetrasulfonate (AlPcS) in vitro. "
09/01/1992 - "This work relates to studies on modes of phototoxicity by tetrasulfonated aluminium phthalocyanine (AlPcS4), tetrahydroxy- and monosulfonated meso-tetraphenylporphines (3-THPP and TPPS1) on culture cells. "
|5.||Atherosclerotic Plaque (Atheroma)
09/01/2012 - "The investigation was undertaken to study the accumulation of the photosensitizer Photosens in arterial atherosclerotic plaques and to immunohistochemically identify cellular elements in them. "
09/01/2012 - "[In vitro accumulation of the photosensitizer Photosens in the atherosclerotic plaque of the human carotid artery]."
|1.||Photochemotherapy (Photodynamic Therapy)